Panels that include markers of cardiac wall stress (e.g., NT-proBNP), renal tubular injury (KIM-1, NGAL), fibrosis (pro-collagen peptides, POSTN), and regulatory molecules (selected miRNAs) could provide a comprehensive molecular fingerprint of CRS activity in a patient. The gene discussed is POSTN; the disease is congenital rubella syndrome.